Postnatal early overnutrition dysregulates the intrarenal renin-angiotensin system and extracellular matrix-linked molecules in juvenile male rats

Journal of Nutritional Biochemistry

Volumn 23, Issue 8, 2012, Pages 937-945

  Yim, Hyung Eun ^a   Ha, Kee Soo ^a   Bae, In Sun ^a   Yoo, Kee Hwan ^a   Hong, Young Sook ^a   Lee, Joo Won ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Extracellular matrix; Kidney development; Obesity; Renin angiotensin system

Indexed keywords

ADIPONECTIN; ANGIOTENSIN RECEPTOR; GELATINASE B; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHILDHOOD OBESITY; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GLOMERULOSCLEROSIS; HYPERLEPTINEMIA; KIDNEY CELL; MACROPHAGE; MALE; NONHUMAN; OVERNUTRITION; PERINATAL PERIOD; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

ANIMALS; CELL PROLIFERATION; DOWN-REGULATION; EXTRACELLULAR MATRIX; FEMALE; MALE; MATRIX METALLOPROTEINASE 9; OVERNUTRITION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN; RENIN-ANGIOTENSIN SYSTEM; UP-REGULATION;

RATTUS;

EID: 84864009317     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.04.020     Document Type: Article

References (38)

1. Baker J.L., Olsen L.W., Sorensen T.I. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007, 357:2329-2337.
2. Mitchell G.A. Genetics, physiology and perinatal influences in childhood obesity: view from the chair. Int J Obes 2009, 33(Suppl 1):S41-S47.
3. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008, 359:61-73.
4. Stettler N., Zemel B.S., Kumanyika S., Stallings V.A. Infant weight gain and childhood overweight status in a multicenter, cohort study. Pediatrics 2002, 109:194-199.
5. Stettler N., Stallings V.A., Troxel A.B., Zhao J., Schinnar R., Nelson S.E., et al. Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation 2005, 111:1897-1903.
6. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006, 144:21-28.
7. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004, 291:844-850.
8. Wahba I.M., Mak R.H. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007, 2:550-562.
9. Engeli S. Role of the renin-angiotensin-aldosterone system in the metabolic syndrome. Contrib Nephrol 2006, 151:122-134.
10. Choi B.M., Yoo K.H., Bae I.S., Oh M.H., Hong Y.S., Lee J.W., Kim S.K. Angiotensin-converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney. Pediatr Res 2005, 57:115-123.
11. Yim H.E., Kim M.K., Bae I.S., Kim J.H., Choi B.M., Yoo K.H., et al. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney. Pediatr Nephrol 2006, 21:1377-1388.
12. Yim H.E., Yoo K.H., Bae I.S., Jang G.Y., Hong Y.S., Lee J.W. Aldosterone regulates cellular turnover and mitogen-activated protein kinase family expression in the neonatal rat kidney. J Cell Physiol 2009, 219:724-733.
13. Gurley S.B., Coffman T.M. The renin-angiotensin system and diabetic nephropathy. Semin Nephrol 2007, 27:144-152.
14. Ronco P., Chatziantoniou C. Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives. Kidney Int 2008, 74:873-878.
15. Lelongt B., Ronco P. Role of matrix metalloproteinases in kidney development and glomerulopathy: lessons from transgenic mice. Nephrol Dial Transplant 2002, 17:28-31.
16. Ma L.J., Nakamura S., Aldigier J.C., Rossini M., Yang H., Liang X., et al. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 2005, 16:966-976.
17. Boullu-Ciocca S., Dutour A., Guillaume V., Achard V., Oliver C., Grino M. Postnatal diet-induced obesity in rats upregulates systemic and adipose tissue glucocorticoid metabolism during development and in adulthood: its relationship with the metabolic syndrome. Diabetes 2005, 54:197-203.
18. Plagemann A., Harder T., Rake A., Voits M., Fink H., Rohde W., Dörner G. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Res 1999, 836:146-155.
19. Ahrén B., Månsson S., Gingerich R.L., Havel P.J. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. Am J Physiol 1997, 273:R113-R120.
20. Wlodek M.E., Westcott K., Siebel A.L., Owens J.A., Moritz K.M. Growth restriction before or after birth reduces nephron number and increases blood pressure in male rats. Kidney Int 2008, 74:187-195.
21. Serradeil-Le Gal C., Raufaste D., Brossard G., Pouzet B., Marty E., Maffrand J.P., Le Fur G. Characterization and localization of leptin receptors in the rat kidney. FEBS Lett 1997, 404:185-191.
22. Han D.C., Isono M., Chen S., Casaretto A., Hong S.W., Wolf G., Ziyadeh F.N. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 2001, 59:1315-1323.
23. Kshatriya S., Reams G.P., Spear R.M., Freeman R.H., Dietz J.R., Villarreal D. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis. Curr Opin Nephrol Hypertens 2010, 19:72-78.
24. Chen Y., Lasaitiene D., Friberg P. The renin-angiotensin system in kidney development. Acta Physiol Scand 2004, 181:529-535.
25. Samuelsson A.M., Morris A., Igosheva N., Kirk S.L., Pombo J.M., Coen C.W., et al. Evidence for sympathetic origins of hypertension in juvenile offspring of obese rats. Hypertension 2010, 55:76-82.
26. Woods L.L., Ingelfinger J.R., Nyengaard J.R., Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001, 49:460-467.
27. Weber K.T., Sun Y., Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994, 23:869-877.
28. Stoll M., Steckelings U.M., Paul M., Bottari S.P., Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995, 95:651-657.
29. Booz G.W., Baker K.M. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 1996, 28:635-640.
30. Sahajpal V., Ashton N. Renal function and angiotensin AT1 receptor expression in young rats following intrauterine exposure to a maternal low-protein diet. Clin Sci (Lond) 2003, 104:607-614.
31. Sahajpal V., Ashton N. Increased glomerular angiotensin II binding in rats exposed to a maternal low protein diet in utero. Physiol 2005, 563:193-201.
32. McMullen S., Gardner D.S., Langley-Evans S.C. Prenatal programming of angiotensin II type 2 receptor expression in the rat. Br J Nutr 2004, 91:133-140.
33. Bolbrinker J., Markovic S., Wehland M., Melenhorst W.B., van Goor H., Kreutz R. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension. J Pharmacol Exp Ther 2006, 316:8-16.
34. Hertig A., Rondeau E. Plasminogen activator inhibitor type 1: the two faces of the same coin. Curr Opin Nephrol Hypertens 2004, 13:39-44.
35. Eitzman D.T., McCoy R.D., Zheng X., Fay W.P., Shen T., Ginsburg D., Simon R.H. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 1996, 97:232-237.
36. Fogo A.B. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis 2000, 35:179-188.
37. Lelongt B., Legallicier B., Piedagnel R., Ronco P.M. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases?. Curr Opin Nephrol Hypertens 2001, 10:7-12.
38. Van Huyen J.P., Viltard M., Nehiri T., Freund N., Bélair M.F., Martinerie C., et al. Expression of matrix metalloproteinases MMP-2 and MMP-9 is altered during nephrogenesis in fetuses from diabetic rats. Lab Invest 2007, 87:680-689.